Multicenter Cohort Study of Infliximab Pharmacokinetics and Therapy Response in Pediatric Acute Severe Ulcerative Colitis-Reference-Cited by-同舟云学术

Multicenter Cohort Study of Infliximab Pharmacokinetics and Therapy Response in Pediatric Acute Severe Ulcerative Colitis

Published:2023-05 Issue:5 Volume:21 Page:1338-1347
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Whaley Kaitlin G.,Xiong Ye,Karns Rebekah,Hyams Jeffrey S.,Kugathasan Subra,Boyle Brendan M.,Walters Thomas D.,Kelsen Judith,LeLeiko Neal,Shapiro Jason,Waddell Amanda,Fox Sejal,Bezold Ramona,Bruns Stephanie,Widing Robin,Haberman Yael,Collins Margaret H.,Mizuno Tomoyuki,Minar Phillip,D’Haens Geert R.,Denson Lee A.,Vinks Alexander A.,Rosen Michael J.^ORCID

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference24 articles.

1. Clinical outcome of ulcerative colitis in children;Hyams;J Pediatr,1996

2. The prevalence and geographic distribution of Crohn’s disease and ulcerative colitis in the United States;Kappelman;Clin Gastroenterol Hepatol,2007

3. Acute severe ulcerative colitis in children: a systematic review;Turner;Inflamm Bowel Dis,2011

4. Severe pediatric ulcerative colitis: a prospective multicenter study of outcomes and predictors of response;Turner;Gastroenterology,2010

5. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study;Turner;Gastroenterology,2007

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting complications in paediatric ulcerative colitis: A longitudinal multicentre cohort study;Alimentary Pharmacology & Therapeutics;2024-09-10

2. Ustekinumab for anti-tumor necrosis factor refractory pediatric ulcerative colitis: a promising approach towards endoscopic healing;Intestinal Research;2024-07-31

3. Precision medicine: Externally validated explainable AI support tool for predicting sustainability of infliximab and vedolizumab in ulcerative colitis;Digestive and Liver Disease;2024-07

4. Infliximab in paediatric inflammatory bowel disease: External evaluation of population pharmacokinetic models;British Journal of Clinical Pharmacology;2024-06-06

5. Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology;Therapeutic Drug Monitoring;2024-04-17